SP–304 is an analog of uroguanylin, a natural hormone produced in the gastro–intestinal (GI) tract that is a key regulator of intestinal function. SP–304 works by activating a unique receptor, the ...
Synergy Pharmaceuticals announced the initiation of dosing in a Phase 2a clinical trial of SP-304 in patients with chronic constipation (CC). This trial is a randomized, double-blind, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results